This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma detection, in a screening population, with and without chronic gastroesophageal reflux disease.
This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma detection, in a screening population, with and without chronic gastroesophageal reflux disease.
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
-
Mayo Clinic Arizona, Scottsdale, Arizona, United States, 85259
Mayo Clinic Jacksonville, Jacksonville, Florida, United States, 32224
Mayo Clinic Health Systems - Austin, Austin, Minnesota, United States, 55912
Mayo Clinic Health Systems - Mankato, Mankato, Minnesota, United States, 56001
Mayo Clinic Rochester, Rochester, Minnesota, United States, 55905
Northwell Health, New Hyde Park, New York, United States, 11040
Baylor Scott & White Research Institute, Dallas, Texas, United States, 75246
Mayo Clinic Health System-Eau Claire, Eau Claire, Wisconsin, United States, 54701
Mayo Clinic Health System-Franciscan Healthcare, La Crosse, Wisconsin, United States, 54601
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 90 Years
ALL
Yes
Mayo Clinic,
Prasad G. Iyer, M.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic
2027-01-02